| PD-L1 expression in nonclear-cell renal cell carcinoma TK Choueiri, AP Fay, KP Gray, M Callea, TH Ho, L Albiges, J Bellmunt, ... Annals of oncology 25 (11), 2178-2184, 2014 | 328 | 2014 |
| Differential expression of PD-L1 between primary and metastatic sites in clear-cell renal cell carcinoma M Callea, L Albiges, M Gupta, SC Cheng, EM Genega, AP Fay, J Song, ... Cancer immunology research 3 (10), 1158-1164, 2015 | 313* | 2015 |
| Single-molecule protein sensing in a nanopore: a tutorial N Varongchayakul, J Song, A Meller, MW Grinstaff Chemical Society Reviews 47 (23), 8512-8524, 2018 | 236 | 2018 |
| p63-expressing cells are the stem cells of developing prostate, bladder, and colorectal epithelia JC Pignon, C Grisanzio, Y Geng, J Song, RA Shivdasani, S Signoretti Proceedings of the National Academy of Sciences 110 (20), 8105-8110, 2013 | 236 | 2013 |
| Mutations in TSC1, TSC2, and MTOR are associated with response to rapalogs in patients with metastatic renal cell carcinoma DJ Kwiatkowski, TK Choueiri, AP Fay, BI Rini, AR Thorner, G De Velasco, ... Clinical Cancer Research 22 (10), 2445-2452, 2016 | 218 | 2016 |
| Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors BM Emerling, JB Hurov, G Poulogiannis, KS Tsukazawa, R Choo-Wing, ... Cell 155 (4), 844-857, 2013 | 182 | 2013 |
| Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor G Lu, Q Zhang, Y Huang, J Song, R Tomaino, T Ehrenberger, E Lim, ... Cancer Cell 26 (2), 222-234, 2014 | 102 | 2014 |
| Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study AP Fay, S Signoretti, M Callea, GH Telό, RR McKay, J Song, I Carvo, ... Journal for immunotherapy of cancer 3 (1), 1-8, 2015 | 97 | 2015 |
| Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor‐risk metastatic renal cell carcinoma MD Michaelson, RR McKay, L Werner, MB Atkins, EM Van Allen, ... Cancer 121 (19), 3435-3443, 2015 | 85 | 2015 |
| From Simple to Architecturally Complex Hydrogel Scaffolds for Cell and Tissue Engineering Applications: Opportunities Presented by Two‐Photon Polymerization J Song, C Michas, CS Chen, AE White, MW Grinstaff Advanced healthcare materials 9 (1), 1901217, 2020 | 80 | 2020 |
| Anti-S1P antibody as a novel therapeutic strategy for VEGFR TKI-resistant renal cancer L Zhang, X Wang, AJ Bullock, M Callea, H Shah, J Song, K Moreno, ... Clinical Cancer Research 21 (8), 1925-1934, 2015 | 78 | 2015 |
| Single-Molecule Discrimination of Labeled DNAs and Polypeptides Using Photoluminescent-Free TiO2 Nanopores R Wang, T Gilboa, J Song, D Huttner, MW Grinstaff, A Meller ACS nano 12 (11), 11648-11656, 2018 | 54 | 2018 |
| HIF activation causes synthetic lethality between the VHL tumor suppressor and the EZH1 histone methyltransferase AA Chakraborty, E Nakamura, J Qi, A Creech, JD Jaffe, J Paulk, JS Novak, ... Science translational medicine 9 (398), 2017 | 36 | 2017 |
| Inhibition of ALK1 signaling with dalantercept combined with VEGFR TKI leads to tumor stasis in renal cell carcinoma X Wang, N Solban, P Khanna, M Callea, J Song, DC Alsop, RS Pearsall, ... Oncotarget 7 (27), 41857, 2016 | 31 | 2016 |
| Controlled Cell Alignment Using Two‐Photon Direct Laser Writing‐Patterned Hydrogels in 2D and 3D J Song, C Michas, CS Chen, AE White, MW Grinstaff Macromolecular Bioscience 21 (5), 2100051, 2021 | 18 | 2021 |
| Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinoma KM Mahoney, S Jacobus, RS Bhatt, J Song, I Carvo, SC Cheng, ... Clinical genitourinary cancer 14 (4), 304-313. e6, 2016 | 10 | 2016 |
| On‐Site, On‐Demand 3D‐Printed Nasopharyngeal Swabs to Improve the Access of Coronavirus Disease‐19 Testing J Song, J Korunes‐Miller, R Banerji, Y Wu, S Fazeli, H Zheng, B Orr, ... Global Challenges 5 (11), 2100039, 2021 | 6 | 2021 |
